Clinical Trial Update: Assessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab Administration on Coronary Plaque Volumes Measured by Coronary Computed Tomography Angiography (CCTA) in Patients With Homozygous Familial Hypercholesterolemia (HoFH)

View source ↗

Summary

A clinical trial update evaluating intensified lipid-lowering therapy with guidelines-based evinacumab for Homozygous Familial Hypercholesterolemia and its effe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Homozygous Familial Hypercholesterolemia

Drugs mentioned

• Evinacumab (evinacumab)

Snippet

Sponsor: Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) | Conditions: Homozygous Familial Hypercholesterolemia (HoFH), Coronary Computed Tomography Angiography | Status: NOT_YET_RECRUITING